1026-Ferroptosis Inhibition Enhances Organ Graft Function

Paper Talk · May 25, 2026 · 23m

This research introduces FXT-001, a novel pharmacological inhibitor designed to combat ferroptosis, a form of iron-dependent cell death that occurs during organ transplantation. The authors demonstrate that ischemia-reperfusion injury triggers a significant burst of lipid peroxidation in human and animal grafts, leading to severe tissue damage and organ dysfunction. Through preclinical testing in porcine and human models, the study shows that treating liver and lung grafts with FXT-001 significantly preserves organ viability, reduces injury markers, and improves overall metabolic function…